Evidence 360: Real World Evidence Conference 2025 USA
Event at-a-glance
The EVIDENCE 360: RWE, Pricing & Reimbursement Summit USA, hosted by Veridon Global on 26th-27th June 2025 in Philadelphia, USA, is a groundbreaking two-day event dedicated to advancing the role of Real-World Evidence (RWE) in shaping healthcare policies and market access strategies. This summit is a convergence of healthcare professionals, pharmaceutical professionals, policymakers, researchers, and data scientists, united to address the most pressing challenges and opportunities in RWE, pricing strategies, and reimbursement frameworks in the U.S. context. Designed to facilitate in-depth knowledge sharing and collaborative problem-solving, the summit will spotlight innovative approaches for leveraging RWE to improve patient outcomes and optimize healthcare costs.
Discussions will cover critical topics such as harnessing AI, machine learning, and big data to revolutionize RWE analysis; overcoming disparities in the U.S. reimbursement landscape; incorporating Patient-Reported Outcomes (PROs) to drive patient-centric care; and adapting pricing models for precision medicine. Additionally, the event will delve into regulatory challenges, including FDA acceptance of RWE, and explore how RWE can be strategically utilized in Health Technology Assessments (HTAs). By providing actionable insights and fostering connections among industry leaders, this summit will serve as a catalyst for innovation in healthcare decision-making. Join us in Philadelphia to be part of this transformative conversation shaping the future of evidence-based.
Key Topics
- Bridging the gap between clinical trial data and real-world outcomes to improve healthcare access
- Using AI, machine learning, and big data to generate actionable insights from real-world datasets
- Leveraging Patient-Reported Outcomes (PROs) and patient-centric data to optimize access strategies
- Navigating Fragmented Reimbursement Policies in the U.S.
- Exploring differences between U.S. HTA practices and global approaches
- Aligning pricing and reimbursement strategies with evolving healthcare policies
Why join us?
- Gain insights into the latest RWE trends and how they influence pricing and reimbursement strategies in USA.
- Network with key industry leaders and regulators shaping the future of healthcare policy and market access.
- Learn about the role of RWE in regulatory decision-making and how it influences health technology assessments (HTAs).
- Explore the integration of AI and digital health in driving more efficient and effective reimbursement decisions.
- Collaborate on overcoming the key challenges in integrating RWE and enhancing patient outcomes through data-driven decisions.
Target Audience
- Pharmaceutical and Biotech Companies: Executives, decision-makers, and researchers involved in drug development, market access, and pricing strategies.
- Regulators and Policy Makers – Representatives from healthcare authorities, regulatory bodies, and health technology assessment (HTA) agencies across USA.
- Researchers– Experts using RWE to assess treatment outcomes, improve healthcare models, and support regulatory submissions.
- Advisors and Payers – Professionals providing guidance on pricing strategies, reimbursement, and RWE implementation.
- Investors – Individuals and firms interested in funding innovation in healthcare, particularly in RWE and value-based pricing models.
Speakers
Sunil Dravida
Sanket Shah
Lin Wang
Charles Makin
Ravi Iyer
Sandipan Bhattacharjee
Sumati Rao
Amit Raval
Kunal Kaushal
Paresh Chaudhari
Boxiong Tang
Yash Jalundhwala
Beni Turner
Kavita Sail
Nazanin Mehnin
Jennifer Onwumeh-Okwundu
Sponsors
Silver Sponsor
Associate Sponsor
Kimpton Hotel Palomar, Philadelphia, 117 South 17th Street, Philadelphia, PA 19103
What is Real-World Evidence (RWE)?
Real-World Evidence (RWE) is playing an increasingly critical role in healthcare decision-making. But what is Real-World Evidence? It encompasses data collected outside of traditional clinical trials, offering insights into how treatments perform in everyday practice. Join us at Evidence 360 to explore the full potential of RWE and its applications.
The Impact of Real-World Evidence on Pharma
For the real world evidence pharma is emerging as a game-changing tool. It is used to optimize drug development, demonstrate product value, and gain regulatory approval. At Evidence 360, discover how leading pharmaceutical companies are leveraging RWE to stay ahead in a competitive market.
Unlocking the Power of RWE (Real World Evidence)
RWE real world evidence offers a more complete view of treatment effects than clinical trials alone. By analyzing data from diverse sources, stakeholders can make informed decisions that enhance patient outcomes. Learn how to effectively harness the power of RWE at Evidence 360.
Navigating the Real-World Evidence Market
The real-world evidence market is rapidly expanding, creating new opportunities for innovation and collaboration. Understand the dynamics of this evolving market and how your organization can benefit from the growing demand for RWE solutions. Join our speakers to know more about RWE market.
Leading Real World Evidence Companies
Connect with real world evidence companies at the forefront of data analytics, consulting, and technology solutions. Discover how these companies are helping organizations generate actionable insights from real-world data and drive better healthcare outcomes. At Evidence 360, you will get a chance to meet our partners that are leading RWE companies.
Real World Data vs. Real World Evidence: Understanding the Difference
While real world data (RWD) forms the foundation, real world evidence (RWE) is the actionable insights derived from that data through analysis and interpretation. Gain clarity on the distinction between RWD and RWE and how to effectively leverage both at Evidence 360.
Enhancing Clinical Trials with Real World Evidence
Real world evidence clinical trials can complement traditional trials by providing valuable insights into treatment effectiveness, patient adherence, and long-term outcomes. Explore how RWE is being used to optimize clinical trial design and accelerate drug development.
The Role of Real World Evidence Consulting
Real world evidence consulting services can help organizations navigate the complexities of RWE generation, analysis, and implementation. Discover how experienced consultants can guide your organization in leveraging RWE to achieve your strategic goals.
Real World Evidence Courses: Build Your Expertise
Looking to deepen your understanding of RWE? Our summit offers opportunities to learn about real world evidence courses and training programs that can equip you with the skills and knowledge needed to succeed in this rapidly evolving field.
Choosing the Right Real World Evidence Platform
A robust real world evidence platform is essential for efficient data management, analysis, and reporting. Explore the features and capabilities of leading RWE platforms and how they can support your organization’s RWE initiatives.